Barriers to GeneXpert utilization for tuberculosis detection at a regional referral hospital in Malawi: a qualitative study

马拉维一家区域转诊医院使用GeneXpert进行结核病检测的障碍:一项定性研究

阅读:2

Abstract

INTRODUCTION: GeneXpert is the recommended diagnostic test for HIV-associated tuberculosis (TB). However, GeneXpert utilization is suboptimal in many countries. We explored the utilization of GeneXpert in an urban, regional referral hospital in northern Malawi using qualitative methods. METHODS: in this cross-sectional qualitative study, a purposive sample of eight key informants from the TB clinic and laboratory was selected from outpatient and inpatient wards. An interview guide was used to conduct in-depth interviews to explore barriers to GeneXpert utilization. Interview data were analyzed using thematic analysis. RESULTS: barriers to GeneXpert utilization appeared in three main themes: healthcare providers, institutions and operational-related factors. Healthcare provider factors included inadequate knowledge and training on differences in eligibility criteria for testing and GeneXpert algorithms by clinicians and laboratory technicians and poor interdepartmental communication. Institutional factors included staff shortages, heavy workloads and financial constraints. Operational factors included technical factors, e.g. power interruptions, GeneXpert module failures and poor sample quality and the restrictiveness of the algorithm. CONCLUSION: the study identified multiple factors that lead to GeneXpert underutilization. GeneXpert-specific training is required to address many of the provider-related barriers to utilization. This study highlighted the importance of assessing context-specific barriers to inform interventions to improve GeneXpert utilization.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。